Clinical Trial Update: Fast Titration in the Treatment of Schizophrenia, Taiwan [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fast titration for schizophrenia in Taiwan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED